Related Experiment Video
Updated: Jun 20, 2026

07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
A passively suspended Tesla pump left ventricular assist device.
Valentin Izraelev1, William J Weiss, Bryan Fritz
1Advanced Bionics, Inc., Hopkins, Minnesota, USA.
Summary
A novel passively suspended left ventricular assist device (LVAD) pump was designed using computational fluid dynamics. Initial tests show promising blood flow and low hemolysis, suggesting potential for advanced cardiac support.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Fluid Dynamics
Background:
- Left ventricular assist devices (LVADs) are crucial for managing advanced heart failure.
- Current LVADs face challenges including hemolysis and device longevity.
- A passively suspended pump design offers potential advantages in reducing mechanical stress on blood components.
Purpose of the Study:
- To describe the design and initial performance of a new passively suspended Tesla-type LVAD blood pump.
- To evaluate the pump's fluid dynamics, hemocompatibility, and preliminary in vivo performance.
- To assess the feasibility of using computational fluid dynamics (CFD) in the design process.
Main Methods:
- Utilized computational fluid dynamics (CFD) for pump design and analysis.
- Developed a prototype 50 mm diameter, 75 mm length pump.
- Employed buoyant centering force (rotor density < blood) and axial magnetic force for rotor suspension.
- Conducted flow rate, head rise, and hemolysis testing.
Main Results:
- The pump achieved a flow rate of up to 10 L/min at a 70 mm Hg head rise at 8,000 RPM.
- Demonstrated a normalized index of hemolysis below 0.02 mg/dL for flows between 2 and 9.7 L/min.
- Incorporated an inlet pressure sensor for control and showed encouraging initial in vivo results.
Conclusions:
- The passively suspended Tesla-type LVAD pump design shows promising hemocompatibility and performance characteristics.
- CFD analysis is effective in designing advanced LVAD components.
- Further CFD refinement and endurance testing are warranted for clinical translation.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
